Ventetuolo CE, Praestgaard A, Palevsky HI, Klinger JR, Halpern SD, Kawut SM: Sex and hemodynamics in pulmonary arterial hypertension. Eur Respir J 43(2): 523-30, February 2014.
Goncharov DA, Kudryashova TV, Ziai H, Ihida-Stansbury K, DeLisser H, Krymskaya VP, Tuder RM, Kawut SM, Goncharova EA. : mTORC2 coordinates pulmonary artery smooth muscle cell metabolism, proliferation and survival in pulmonary arterial hypertension. Circulation 129(8): 864-74, February 2014.
Whitman I, Patel VV, Soliman EZ, Bluemke DA, Praestgaard A, Jain A, Herrington D, Lima JAC, Kawut SM: Validity of the surface electrocardiogram criteria for right ventricular hypertrophy: The MESA - Right Ventricle Study. JACC(13), 5435, September 2014.
Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, Kalhan R, Lima JAC, Liu C-Y, Michos ED, Prince MR, Rabbani L, Rabinowitz D, Shimbo D, Shea S, Barr RG: Pulmonary hyperinflation and left ventricular mass: The Multi-Ethic Study of Atherosclerosis COPD Study. Circulation 127(14): 1503-11, August 2013.
Grau M, Graham Barr R, Lima JA, Hoffman EA, Bluemke DA, Carr JJ, Chahal H, Enright PL, Jain A, Prince MR, Kawut SM: Percent emphysema and right ventricular structure and function: The MESA Lung and MESA-RV Studies. Chest 144(1): 136-44, July 2013.
Fritz J, Blair C, Oudiz R, Dufton C, Olschewski H, Despain D, Gillies H, Kawut SM: Baseline and follow-up six minute walk distance and BNP predict 2-year mortalilty in pulmonary arterial hypertension. Chest 143(2): 315-23, February 2013.
Kawut SM, Barr RG, Lima JA, Praestgaard A, Johnson WC, Chahal H, Ogunyankin KO, Bristow MR, Kizer JR, Tandri H, Bluemke DA.
: Right ventricular structure is associated with the risk of heart failure and cardiovascular death: The MESA-Right Ventricle Study. Circulation 126(14): 1681-8, October 2012.
Gabler NB, French B, Strom BL, Liu Z, Palevsky HI, Taichman DB, Kawut
SM, Halpern SD: Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. Chest 141(1): 20-6, January 2012.
Gabler NM, French B, Strom BL, Palevsky HI, Taichman DB, Kawut SM, Halpern SD: Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation 126(3): 349-56, Jul 2012.
back to top
Last updated: 10/20/2017
The Trustees of the University of Pennsylvania